---
title: "These Analysts Raise Their Forecasts On VeriSign After Strong Q1 Results"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284040649.md"
description: "VeriSign, Inc (NASDAQ:VRSN) reported strong Q1 earnings, with earnings of $2.34 per share and sales of $428.9 million, both exceeding analyst expectations. The company raised its FY2026 sales guidance to $1.730 billion-$1.745 billion. Despite the positive results, shares fell 5.3% to $262.27. Analysts from Baird and JP Morgan adjusted their price targets, with Baird raising it to $355 and JP Morgan to $278, maintaining their ratings of Outperform and Neutral, respectively."
datetime: "2026-04-24T17:29:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284040649.md)
  - [en](https://longbridge.com/en/news/284040649.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284040649.md)
---

# These Analysts Raise Their Forecasts On VeriSign After Strong Q1 Results

**VeriSign, Inc** (NASDAQ:VRSN) reported upbeat earnings for the first quarter on Thursday.

The company posted quarterly earnings of $2.34 per share which beat the analyst consensus estimate of $2.25 per share. The company reported quarterly sales of $428.900 million which beat the analyst consensus estimate of $425.912 million.

VeriSign raised its FY2026 sales guidance from $1.715 billion-$1.735 billion to $1.730 billion-$1.745 billion.

“Through the first quarter of 2026 we continued to execute on our primary mission, extending into its 29th year our unparalleled record of providing 100% availability of our resolution service for the .com/.net domains. For the quarter, we delivered both steady growth in registrations and solid financial results,” said Jim Bidzos, Executive Chairman, President and Chief Executive Officer.

VeriSign shares fell 5.3% to trade at $262.27 on Friday.

These analysts made changes to their price targets on VeriSign following earnings announcement.

-   Baird analyst Robert Oliver maintained VeriSign with an Outperform rating and raised the price target from $305 to $355.
-   JP Morgan analyst Alexei Gogolev maintained the stock with a Neutral and raised the price target from $273 to $278.

**Considering buying VRSN stock? Here’s what analysts think:**

_Photo via Shutterstock_

### Related Stocks

- [VRSN.US](https://longbridge.com/en/quote/VRSN.US.md)
- [IDGT.US](https://longbridge.com/en/quote/IDGT.US.md)
- [DTCR.US](https://longbridge.com/en/quote/DTCR.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)

## Related News & Research

- [BOX (BOX) Expected to Announce Earnings on Tuesday](https://longbridge.com/en/news/286864296.md)
- [Nebius Group Analysts Increase Their Forecasts Following Q1 Earnings](https://longbridge.com/en/news/286435619.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)
- [Earnings Beat: Odfjell Drilling Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models](https://longbridge.com/en/news/286515920.md)